title: GM-CSF in the treatment of acute myeloid leukemia.
authors.affiliation: Medizinische Klinik und Polyklinik, Medizin A, Munster, Germany.
authors.forename: W
authors.initials: W
authors.lastname: Hiddemann
authors.forename: G
authors.initials: G
authors.lastname: Maschmeyer
authors.forename: W D
authors.initials: WD
authors.lastname: Ludwig
authors.forename: M
authors.initials: M
authors.lastname: Königsmann
authors.forename: M
authors.initials: M
authors.lastname: Zühlsdorf
authors.forename: B
authors.initials: B
authors.lastname: Wörmann
authors.forename: A
authors.initials: A
authors.lastname: Boeckmann
authors.forename: E
authors.initials: E
authors.lastname: Agion-Freire
authors.forename: G
authors.initials: G
authors.lastname: Innig
authors.forename: C
authors.initials: C
authors.lastname: Reuter
mesh_terms: D000208:Acute Disease; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007951:Leukemia, Myeloid / Q000188:drug therapy*; D009503:Neutropenia / Q000139:chemically induced / Q000517:prevention & control*
chemical_list: D000970:Antineoplastic Agents; D016178:Granulocyte-Macrophage Colony-Stimulating Factor